Literature DB >> 17404389

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Alison R Yung1, Hok Pan Yuen, Gregor Berger, Shona Francey, Te-Chieh Hung, Barnaby Nelson, Lisa Phillips, Patrick McGorry.   

Abstract

There is growing interest in the prodromal stage of psychotic disorders, with many services now providing care for these "ultra high risk" (UHR) individuals. However, a reduction in the rate of transition to psychosis has been suspected over the last few years. This has implications for the use of interventions in this population and for the validity of research findings. This study examined the transition rate in one UHR service, the Personal Assessment and Crisis Evaluation Clinic, over the years 1995-2000 and investigated possible causes for the transition rate reduction. There was evidence for a declining transition rate, with each successive year showing a rate 0.80 times that of the preceding year. Functioning and symptom level were not responsible for the change. The decreased transition rate was partly explained by a reduction in the duration of symptoms of patients prior to receiving help. That is, UHR individuals are being detected and provided with care earlier than in the past. Thus, the decline in transition rate may be due to treatment being more effective at this very early stage of illness or it may be due to finding more false positives who were never at risk of psychosis, ie, a "dilution" effect. Given that it is not possible to distinguish between these alternatives at least phenotypically at present, perhaps it is time to rethink the role and practice of UHR clinics. Patients presenting to them need help. It may be that we need to aim to prevent a range of target syndromes.

Entities:  

Mesh:

Year:  2007        PMID: 17404389      PMCID: PMC2526154          DOI: 10.1093/schbul/sbm015

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  35 in total

1.  The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior.

Authors:  P Møller; R Husby
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.

Authors:  Alison R Yung; Carrie Stanford; Elizabeth Cosgrave; Eoin Killackey; Lisa Phillips; Barnaby Nelson; Patrick D McGorry
Journal:  Schizophr Res       Date:  2006-04-21       Impact factor: 4.939

3.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 4.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

Review 5.  Prospective investigations of the prodromal state of schizophrenia: review of studies.

Authors:  K A Olsen; B Rosenbaum
Journal:  Acta Psychiatr Scand       Date:  2006-04       Impact factor: 6.392

Review 6.  Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.

Authors:  Patrick D McGorry; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Aust N Z J Psychiatry       Date:  2006-08       Impact factor: 5.744

7.  Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability.

Authors:  Alison R Yung; Joe A Buckby; Sue M Cotton; Elizabeth M Cosgrave; Eoin J Killackey; Carrie Stanford; Katherine Godfrey; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

8.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

Review 9.  Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis.

Authors:  Warrick J Brewer; Stephen J Wood; Lisa J Phillips; Shona M Francey; Christos Pantelis; Alison R Yung; Barbara Cornblatt; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2006-06-16       Impact factor: 9.306

Review 10.  Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Authors: 
Journal:  Aust N Z J Psychiatry       Date:  2005 Jan-Feb       Impact factor: 5.598

View more
  109 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.

Authors:  Nikolaos Koutsouleris; Stefan Borgwardt; Eva M Meisenzahl; Ronald Bottlender; Hans-Jürgen Möller; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

3.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

Review 4.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

5.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

6.  Baby or bathwater? Referrals of "non-cases" in a targeted early identification intervention for psychosis.

Authors:  Gerald Jordan; Miriam Kinkaid; Srividya N Iyer; Ridha Joober; Karen Goldberg; Ashok Malla; Jai L Shah
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-03-14       Impact factor: 4.328

7.  Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.

Authors:  Christoph U Correll; Julie B Penzner; Anne M Frederickson; Jessica J Richter; Andrea M Auther; Christopher W Smith; John M Kane; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2007-05-02       Impact factor: 9.306

Review 8.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

9.  'At-risk' for psychosis research: where are we heading?

Authors:  A Lin; B Nelson; A R Yung
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

10.  Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health.

Authors:  S M Cotton; K M Filia; A Ratheesh; K Pennell; S Goldstone; P D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-01       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.